113 related articles for article (PubMed ID: 1320604)
1. Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli: effect on morphology and haemolysin activity.
Guan L; Burnham JC
J Antimicrob Chemother; 1992 May; 29(5):529-38. PubMed ID: 1320604
[TBL] [Abstract][Full Text] [Related]
2. Analysis of macromolecular biosynthesis to define the quinolone-induced postantibiotic effect in Escherichia coli.
Guan L; Blumenthal RM; Burnham JC
Antimicrob Agents Chemother; 1992 Oct; 36(10):2118-24. PubMed ID: 1280055
[TBL] [Abstract][Full Text] [Related]
3. Effect of suprainhibitory concentrations of quinolones on hydrophobicity and motility of Serratia marcescens.
Majtán V; Majtánová L
Microbios; 2000; 102(402):79-88. PubMed ID: 10885498
[TBL] [Abstract][Full Text] [Related]
4. Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms.
Sonstein SA; Burnham JC
Diagn Microbiol Infect Dis; 1993; 16(4):277-89. PubMed ID: 8388327
[TBL] [Abstract][Full Text] [Related]
5. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of enoxacin, enrofloxacin, sparfloxacin, and ciprofloxacin against Escherichia coli strains isolated from diarrheic lambs and kids.
Cid D; Piriz S; Ruiz-Santa-Quiteria JA; Valle J; Garcia S; Vadillo S; de la Fuente R
Antimicrob Agents Chemother; 1994 Oct; 38(10):2469-70. PubMed ID: 7840590
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Escherichia coli type 1 fimbrial expression and adherence to uroepithelial cells following exposure of logarithmic phase cells to quinolones at subinhibitory concentrations.
Breines DM; Burnham JC
J Antimicrob Chemother; 1994 Aug; 34(2):205-21. PubMed ID: 7814281
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
Chemotherapy; 1996; 42(5):354-62. PubMed ID: 8874975
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure.
Wickens HJ; Pinney RJ; Mason DJ; Gant VA
Antimicrob Agents Chemother; 2000 Mar; 44(3):682-7. PubMed ID: 10681338
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
[TBL] [Abstract][Full Text] [Related]
11. In vitro postantibiotic effect of imipenem and enoxacin alone and in combination against Pseudomonas aeruginosa.
Hostacká A
Pharmazie; 1997 Jul; 52(7):544-6. PubMed ID: 9266592
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
[TBL] [Abstract][Full Text] [Related]
13. [Postantibiotic effects and postantibiotic effects of subinhibitory levels of quinolines on Pseudomonas aeruginosa].
Hostacká A
Epidemiol Mikrobiol Imunol; 1996 May; 45(2):56-8. PubMed ID: 8756401
[TBL] [Abstract][Full Text] [Related]
14. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL16.
Lewin CS; Amyes SG; Smith JT
Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):731-3. PubMed ID: 2506044
[TBL] [Abstract][Full Text] [Related]
16. Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates.
Carbone M; Pennisi MG; Masucci M; De Sarro A; Giannone M; Fera MT
Vet Microbiol; 2001 Jul; 81(1):79-84. PubMed ID: 11356321
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
Azadian BS; Talboys CA; Roberts AP
J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
[No Abstract] [Full Text] [Related]
18. Overview of the fluoroquinolone antibiotics.
Just PM
Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of fluoroquinolones in combination with zidovudine.
Lewin CS; Allen RA; Amyes SG
J Med Microbiol; 1990 Oct; 33(2):127-31. PubMed ID: 2121991
[TBL] [Abstract][Full Text] [Related]
20. Loss of bactericidal activities of quinolones during the post-antibiotic effect induced by rifampicin.
Meng X; Nightingale CH; Sweeney KR; Quintiliani R
J Antimicrob Chemother; 1994 Apr; 33(4):721-8. PubMed ID: 8056690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
